HOWMET LIMITED

Financial Health Assessment: HOWMET LIMITED

1. Financial Health Score: B (Incomplete Data - Structural Assessment)

Explanation: Based on the available corporate and compliance data, HOWMET LIMITED exhibits a strong structural constitution with no immediate symptoms of administrative distress. However, because the numerical financial data (such as turnover, assets, and liabilities) is not present in the provided records, a full financial diagnosis cannot be completed. The "B" grade reflects excellent corporate governance and filing compliance, with the caveat that the financial vital signs require further testing.

2. Key Vital Signs

• Filing Pulse (Compliance): The company’s filing heartbeat is regular and strong. Accounts are made up to 31 December 2025 and are not overdue. Confirmation statements are also up to date. This indicates a healthy administrative function.
• Corporate Genetics (Ownership Structure): The company is a wholly-owned subsidiary of Howmet Products UK Limited and Arconic Extruded Products (UK) Limited, both of which hold more than 75% of the shares. This suggests strong corporate backing and integration into a larger global group.
• Capital Baseline: The share capital stands at a robust £1,000,002, indicating a solid foundational equity base.
• Organizational Size: The company files "Full" accounts, which tells us it exceeds the thresholds for medium-sized companies. Operating in the non-ferrous metal production and casting industry (SIC codes 24450 and 24540), it is a significant operational entity.

3. Symptoms Analysis & Diagnosis

• Symptoms Analysis: The available data shows no symptoms of distress. The presence of a full board of directors, a company secretary, and up-to-date filings suggests that the company is actively managed and well-governed. The recent resignation of a director in March 2026 appears to be a standard board transition rather than a sign of systemic issues, given the presence of multiple other current directors.
• Diagnosis: The patient is structurally healthy from a corporate governance perspective. The company is an active, well-established entity (incorporated in 1991) operating in the specialized non-ferrous metals sector. As a subsidiary of a larger corporate group, it likely benefits from group-level financial support, though this cannot be confirmed without the actual financial statements.

4. Prognosis & Recommendations

• Prognosis: The future outlook appears stable based on corporate structure. The company is part of the broader Howmet/Arconic group, a major player in aerospace and industrial manufacturing. Its active status and compliant filing history suggest it will continue to operate as a going concern. However, the true financial prognosis—profitability, cash flow health, and solvency—cannot be determined without the balance sheet and profit & loss data.
• Recommendations:
  1. Complete the Diagnostic Panel: Obtain the full annual accounts (balance sheet, P&L, and cash flow statement) to measure financial vital signs such as liquidity, working capital, and profitability.
  2. Monitor Working Capital: Once financials are available, check the Net Current Assets to ensure the company maintains a healthy cash flow and can meet its short-term obligations.
  3. Maintain Governance Hygiene: Continue the current standard of timely filings and strong board oversight to prevent any administrative infections.